Northampton General Hospital is a district general hospital in Northampton, Northamptonshire, England. It is managed by the Northampton General Hospital NHS Trust.

There are 700 beds in Northampton General Hospital.

During the past decade, Northampton General Hospital conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 10 clinical trials were completed, i.e. on average, 43.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northampton General Hospital" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "University College, London" with 4 trials sponsored, "Medical Research Council" with 3 trials sponsored and "Abbott Diabetes Care" with 3 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northampton General Hospital" #1 collaborator was "Cancer Research UK" with 6 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 3 trials as a collaborator, "University of Birmingham" with 2 trials as a collaborator, "University of Oxford" with 2 trials as a collaborator and "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Northampton General Hospital" are "Breast Cancer" (6 trials), "Ovarian Cancer" (6 trials), "Colorectal Cancer" (4 trials), "Fallopian Tube Cancer" (4 trials) and "Alzheimer Disease" (3 trials). Many other conditions were trialed in "Northampton General Hospital" in a lesser frequency.

Most popular intervention types in "Northampton General Hospital" are "Drug" (39 trials), "Procedure" (14 trials), "Other" (10 trials), "Biological" (8 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "quality-of-life assessment" (7 trials), "adjuvant therapy" (5 trials), "cyclophosphamide" (5 trials), "Placebo" (4 trials) and "capecitabine" (4 trials). Other intervention names were less common.

The vast majority of trials in "Northampton General Hospital" are 48 trials for "All" genders, 13 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Northampton General Hospital". undefined are not yet recruiting, 10 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Northampton General Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Northampton General Hospital, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 10 trials that are defined as “Not Applicable".